Pancreatic Cancer Research

ResearcherAntalya Eğitim ve Araştırma HastanesiActive in the last 2 years

Mustafa Yıldız

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7832-5989; OpenAlex author ID A5005730746. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. Uric Acid-Driven Biomarkers and Clinical Outcomes in Metastatic Pancreatic Cancer: A Multicenter Real-World Cohort Study. Last author DOI 10.3390/diagnostics16091296↗
  2. Pan-Immune-Inflammation Value as a Novel Prognostic Biomarker for Advanced Pancreatic Cancer. Last author DOI 10.7759/cureus.71251↗
  3. Expression pattern and prognostic significance of claudin 1, 4 and 7 in pancreatic cancer. Co-author DOI 10.7314/apjcp.2015.16.10.4387↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ahmet Ünlü · 2 shared papers, 2024–2026 · strength 0.54
  2. Asım Armağan Aydın · 2 shared papers, 2024–2026 · strength 0.54
  3. Halil Göksel Güzel · 1 shared paper, 2024 · strength 0.21
  4. Arif Hakan Önder · 1 shared paper, 2024 · strength 0.21
  5. Erkan Kayıkçıoğlu · 1 shared paper, 2024 · strength 0.21
  6. Mustafa Yıldırım · 1 shared paper, 2015 · strength 0.05
  7. Arsenal Sezgin Alikanoğlu · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.